MAMohammed N. Aljehani

Mohammed N. Aljehani

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mohammed N. Aljehani has a total of 23 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Evaluating dysphagia severity and duration in children undergoing airway surgery using the functional oral intake scale

    by Khalid A. Alshehri, Mohammed N. Aljehani, Hassan Alalawi, Mohammed A. Awadh, Abeer Z. Malebari, Anas H. Al-Tammas, Sameera J. Dehaithem, Talal A. Al-Khatib

    Purpose Dysphagia poses a significant concern, particularly within the pediatric population due to the heightened susceptibility of children to silent aspiration, which can lead to numerous complications such as aspiration pneumonia, failure to thrive, dehydration, and poor quality of life. This study aimed to review the duration and extent of postoperative dysphagia-related symptoms and outcomes. Methods A retrospective review was conducted to assess the Functional Oral Intake Scale for Children (FOIS), a grading system used to assess the degree of dysphagia, preoperatively and postoperatively in pediatric patients aged < 14 years who underwent airway procedures between January 2020 and February 2024. Results A total of 28 patients (mean age, 20.05 ± 23.89 months) underwent 37 airway procedures. Among them, 25 (67.6%) were male. The most frequently performed procedures were balloon dilatation (with or without laser) and supraglottoplasty, each accounting for 27% of the surgeries. Postoperative outcomes revealed a mean dysphagia duration of 17.29 ± 42.55 days, with the longest duration observed in patients undergoing vocal cord lateralization (mean: 106.5 ± 146.37 days). Additionally, the ability to feed orally declined postoperatively, with the proportion of patients capable of oral feeding decreasing from 64.9% (24 patients) preoperatively to 40.5% (15 patients) postoperatively. Overall, the FOIS scores increased in the study population. Preoperatively, 10 patients (27%) were classified as FOIS level 1, compared with six patients (16.2%) postoperatively. Additionally, the number of patients with FOIS level 2 increased from three (8.1%) preoperatively to six (16.2%) postoperatively. Conclusion Our study revealed the prevalence and variability of dysphagia in pediatric patients following airway surgery. The duration of postoperative dysphagia in our study population was the longest for vocal fold lateralization procedures, followed by laryngotracheal reconstruction and supraglottoplasty. Children with pre-existing dysphagia, or those who were tube-dependent before surgery, were found to be at a higher risk for experiencing prolonged and persistent feeding difficulties. We highlight the importance of identifying high-risk patients before surgery and routine postoperative swallowing assessments. This should be followed by the involvement of a multidisciplinary care team.

  • Open Access

    Antibiotic resistance patterns of pediatric community-acquired urinary tract infections in a tertiary care center in Jeddah, Saudi Arabia

    by Mohammed A Alsubaie, Abdullah Z Alsuheili, Mohammed N Aljehani, Abdulrahman A Alothman, Abdulaziz S Alzahrani, Hamza A Mohammedfadel, Mazin A Alshehry, Abeer A Alnajjar

    Introduction: Urinary tract infections (UTIs) are common in children. UTIs can lead to serious and permanent damage to the urinary tract if treatment is delayed or insufficient, particularly in repeated infections. Knowledge of antibiotic resistance trends aids in the selection of appropriate empiric antibiotics. There is limited data regarding this in Saudi Arabia. This study aimed to investigate uropathogens and their antibiotic resistance patterns in the pediatric community in a tertiary care center. Methodology: The study population included children aged 0 to 14 years old who had culture-proven UTIs evaluated in the Department of Pediatrics, King Abdulaziz University Hospital in Jeddah, Saudi Arabia from February 2019 to September 2021. Results: Out of 510 UTI episodes, Escherichia coli (54.5%) was the predominant causative pathogen. Of the total episodes, 137 (26.8%) were caused by extended spectrum beta-lactamase (ESBL) producers. In general, the highest resistance was observed against ampicillin (73.2%), cefazolin (54.6%), co-trimoxazole (46%), and cefuroxime (40.6%), whereas amikacin (0.4%), imipenem (0.8%), and meropenem (0.8%) showed the lowest rates of resistance. Conclusions: Antibiotic resistance is a major concern worldwide due to misuse of antibiotics and subsequent rise of multidrug resistant organisms. Our findings highlight the rise in antibiotic resistance, particularly in E. coli strains. Furthermore, ESBL-producing bacteria were responsible for approximately one-third of UTIs. Our study emphasizes the importance of local antibiograms for pediatric community-acquired infections, as it guides clinicians in every center in the choice of appropriate empiric antibiotic treatment.


  • Open Access

    Correction

    by Mohammed N. Aljehani, Ziyad I Alshehri, Faisal A Alharbi, Yaser T. Balbaid, Abdullah M. Wali, Alaa A Alotaibi

    This article has been corrected to fix a typo in the first sentence of the Results section: "A total of 177 patient files were reviewed during the study period, of which 87 patients met the inclusion criteria." The correct amount of patients meeting the inclusion criteria was in fact 89, not 87. This sentence has been amended to reflect this. The journal sincerely regrets that this typo was not caught and corrected prior to publication.


  • Open Access

    Association Between Body Mass Index and Response to Disease-Modifying Therapies in Patients With Relapsing-Remitting Multiple Sclerosis at King Abdulaziz University Hospital: A Retrospective Study

    by Mohammed N Aljehani, Ziyad I Alshehri, Faisal A Alharbi, Yaser T Balbaid, Abdullah M Wali, Alaa A Alotaibi

    Multiple sclerosis (MS) is an immune-mediated inflammatory disease that attacks myelinated axons in the central nervous system, destroying the myelin and axon to varying degrees and producing significant physical disability. So far, many studies have found that having a high body mass index (BMI) is associated with severe autoimmune and neurodegenerative disease course. However, the impact of BMI on disease-modifying therapy (DMT) response in terms of decreasing relapses and improving overall health remains unknown. The study aimed to demonstrate the effect of BMI on DMT responsiveness in patients with relapse-remitting MS at a tertiary hospital. A single-center retrospective study was conducted at a tertiary care center in Jeddah, Saudi Arabia. The study included 89 individuals with relapsing-remitting MS who had their BMI measured within six months of their first clinical relapse, as well as their clinical response to the DMT (number of relapses on a single DMT after six months of initiation) and MRI changes (development of new T2 lesions or gadolinium-enhancing lesions on single DMT six months after DMT initiation). Demographic data revealed a female predominance of 71.9%, and 51.7% of the patients had a normal weight. The most commonly prescribed DMT was Gilenya at 47.2%. A significant relationship was found between BMI and the total number of clinical relapses (p=0.038), with the co-existence of a positive correlation between BMI and the number of relapses after at least six months of initiation of DMT. Additionally, MS patients who had both positive MRI changes and obesity had a significantly higher BMI mean than non-obese. Increased BMI appeared to be associated with a lower response to DMT, as overweight patients had a worse course than normal and underweight patients. Pharmacokinetic differences are the most likely factors implicated in medication responsiveness.